年表作成・共有サービス - pastport

BioHermes SARS-CoV-2 IgG Antibody Test (Lateral Flow Assay) is intended for the
qualitative detection of IgG antibodies to SARS-CoV-2 in human
serum，plasma and venous whole blood. This Test is intended for use as an
aid in identifying individuals with an adaptive immune response to
SARS-CoV-2, indicating recent or prior infection. BioHermes SARS-CoV-2 IgG Antibody Test (Lateral Flow Assay) is with
the following advantages:

-Easy to use, visual reading of results
-Instant result in 10 miutes
-Various sample type: serum; plasma; whole blood
-90.0% sensitivity,100% specificity (compared to PCR confirmed specimen )

The Clinical Value of SARS-CoV-2  IgG detection for COVID-19 are:

-Proven diagnostic criteria to assist the COVID-19 diagnostic

-Assist the exclusion of non-COVID-19 patients

-COVID-19 screening

-Epidemiological follow-up

https://www.biohermesglobal.com/sars-cov-2-antibody-test/